Role of Antifungal Combinations in Difficult to Treat Candida Infections

Area of Science:

• Mycology
• Infectious Diseases
• Pharmacology

Background:

• Candida infections range from superficial to life-threatening, particularly in immunocompromised individuals.
• Candida albicans remains prevalent, but a notable increase in non-albicans Candida species is observed.
• Monotherapy for Candida infections is common, but treatment outcomes are not always favorable.

Purpose of the Study:

• To review the role of drug combinations in treating difficult-to-treat Candida infections.
• To identify specific clinical scenarios where combination therapy is most appropriate.
• To discuss the potential benefits of combination therapy in managing invasive candidiasis.

Main Methods:

• A comprehensive literature search was conducted using PubMed and Google Scholar databases.
• Eligible studies focusing on Candida infections and combination therapy were analyzed.
• Data analysis aimed to determine the optimal use cases for combination antifungal treatment.

Main Results:

• Combination therapy is indicated for refractory candidiasis, endocarditis, meningitis, ocular infections, and osteomyelitis.
• Antifungal drug combinations can enhance treatment efficacy and reduce toxicity.
• This approach may improve patient prognosis in severe and complex Candida infections.

Conclusions:

• Drug combinations represent a viable strategy for managing difficult-to-treat Candida infections.
• Increased clinical studies and case reports are necessary to validate combination therapy's efficacy and safety.
• Further research will solidify the evidence base for using drug combinations in invasive candidiasis.